Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage
Open Access
- 1 February 2006
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (3) , 673-678
- https://doi.org/10.1158/1078-0432.ccr-05-2616
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Activated leukocyte cell adhesion molecule (ALCAM/CD166): Signaling at the divide of melanoma cell clustering and cell migration?Cancer and Metastasis Reviews, 2005
- Interaction of human Thy-1 (CD 90) with the integrin αvβ3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endotheliumOncogene, 2005
- NY‐ESO‐1/LAGE‐1 coexpression with MAGE‐A cancer/testis antigens: A tissue microarray studyInternational Journal of Cancer, 2005
- Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potentialJournal of Cutaneous Pathology, 2004
- Current developments of immunotherapy in the clinicCurrent Opinion in Immunology, 2004
- Peptide vaccine trials for melanoma: preclinical background and clinical resultsSeminars in Cancer Biology, 2003
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- Tissue Distribution of an Immunogenic Melanoma Associated Antigen, D-1Pigment Cell Research, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989